QuestionJuly 14, 2026

My Course Plan Question 8 of 20 Which theropeutic response would the nurse Identify for prescribing lanreotide for o potient with acromegaly? A Relief of bone poin B Prevention of osteopenia C Promotion of epiphyseol closure D Suppression of growth hormone release

My Course Plan Question 8 of 20 Which theropeutic response would the nurse Identify for prescribing lanreotide for o potient with acromegaly? A Relief of bone poin B Prevention of osteopenia C Promotion of epiphyseol closure D Suppression of growth hormone release
My Course Plan
Question 8 of 20
Which theropeutic response would the nurse Identify for prescribing lanreotide for o potient with acromegaly?
A Relief of bone poin
B Prevention of osteopenia
C Promotion of epiphyseol closure
D Suppression of growth hormone release

Solution
4.4(192 votes)

Answer

D. Suppression of growth hormone release Explanation Acromegaly is a hormonal disorder caused by excess growth hormone (GH), often due to a pituitary adenoma. Lanreotide is a somatostatin analog used to treat acromegaly by inhibiting GH secretion. Among the options provided, the therapeutic response aligns with *"Suppression of growth hormone release"* as this directly addresses the primary mechanism of action of lanreotide and its intended effect on acromegaly patients. Other options, such as relief of bone pain, prevention of osteopenia, or promotion of epiphyseal closure, are not specifically related to lanreotide’s primary function in managing acromegaly.

Explanation

Acromegaly is a hormonal disorder caused by excess growth hormone (GH), often due to a pituitary adenoma. Lanreotide is a somatostatin analog used to treat acromegaly by inhibiting GH secretion. Among the options provided, the therapeutic response aligns with *"Suppression of growth hormone release"* as this directly addresses the primary mechanism of action of lanreotide and its intended effect on acromegaly patients.<br /><br />Other options, such as relief of bone pain, prevention of osteopenia, or promotion of epiphyseal closure, are not specifically related to lanreotide’s primary function in managing acromegaly.<br /><br />
Click to rate:

Similar Questions